跳至主要内容
临床试验/NL-OMON53028
NL-OMON53028已完成不适用

ational study of moderate and severe von Willebrand disease in the Netherlands - WiN study (Willebrand disease in the Netherlands)

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 1,000 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
1,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
2 至 64(—)

入选标准

  • 1) haemorrhagic symptoms or
  • a family history of von Willebrand disease
  • 2) vWF antigen <= 30%, lowest measurement counts and/or
  • vWF activity (vWF:RCo of vWF:CB) <= 30%, lowest measurement counts and/or
  • FVIII:C <= 40 %, lowest measurement counts
  • 3) being known in a hemophilia treatment center or
  • if only the diagnose is made in a hemophilia treatment center this must be

排除标准

  • Hemophilia A
  • Carriership of hemophilia A
  • No informed consent

研究者

相似试验